UCLA Launches First-of-Its-Kind Stem Cell Trial to Combat Cancer – Los Angeles Business Journal
Los Angeles Business Journal |
UCLA Launches First-of-Its-Kind Stem Cell Trial to Combat Cancer
Los Angeles Business Journal Scientists at UCLA have launched the first genetically engineered blood stem cell clinical trial to fight cancer thanks to $20 million in voter-approved funds earmarked for stem cell research, university officials announced Monday. The Eli and Edythe … UCLA opens first engineered blood stem cell clinical trial for cancers with the NY-ESO-1 tumor marker |
